The TAPAS study was a single-center, randomized trial that compared thrombus aspiration to conventional PCI in STEMI patients. The study found that thrombus aspiration resulted in improved myocardial perfusion and ST-segment resolution compared to conventional PCI. At 30 days, improved myocardial perfusion predicted lower rates of death and reinfarction. At 1 year follow up, thrombus aspiration was associated with lower mortality and a composite of mortality or non-fatal reinfarction compared to conventional PCI alone.